Fengfeng Cai
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- CRISPR and Genetic Engineering 4
- DNA Repair Mechanisms 3
- Ubiquitin and proteasome pathways 3
- Oncology 16
- Cancer Cells and Metastasis 8
- Co-authors
- Ewelina Biskup (16 shared papers)Xiao Yan Zhong (4 shared papers)Minghong Wang (7 shared papers)Bei Zhang (2 shared papers)Lu Cai (8 shared papers)Weijie Chen (1 shared paper)Zeinab Barekati (1 shared paper)Xiaoyan Lin (3 shared papers)
- Journals
- Tumor Biology (5 papers)Frontiers in Oncology (5 papers)PLoS ONE (2 papers)Oncotarget (2 papers)Nature Communications (2 papers)
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Fengfeng Cai
44 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 327
- Oncology 258
- Molecular Biology 555
- Biotechnology 51
- Toxicology 16
Countries citing papers authored by Fengfeng Cai
This map shows the geographic impact of Fengfeng Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Cai more than expected).
Fields of papers citing papers by Fengfeng Cai
This network shows the impact of papers produced by Fengfeng Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Cai. The network helps show where Fengfeng Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengfeng Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 141 | |
| 2 | 2019 | 119 | |
| 3 | 2021 | 72 | |
| 4 | 2021 | 62 | |
| 5 | 2022 | 58 | |
| 6 | 2016 | 49 | |
| 7 | 2013 | 46 | |
| 8 | 2019 | 46 | |
| 9 | 2021 | 43 | |
| 10 | 2022 | 41 | |
| 11 | 2021 | 38 | |
| 12 | 2011 | 38 | |
| 13 | 2021 | 36 | |
| 14 | 2017 | 28 | |
| 15 | 2012 | 26 | |
| 16 | 2025 | 21 | |
| 17 | 2013 | 20 | |
| 18 | 2014 | 18 | |
| 19 | 2017 | 18 | |
| 20 | 2014 | 18 |
About Fengfeng Cai
Fengfeng Cai is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Immunology, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), Cancer, Hypoxia, and Metabolism (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer Genomics and Diagnostics (4 papers), CRISPR and Genetic Engineering (4 papers), Nanoplatforms for cancer theranostics (4 papers), DNA Repair Mechanisms (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (327 citations), Oncology (258 citations), Molecular Biology (555 citations), Biotechnology (51 citations) and Toxicology (16 citations). Fengfeng Cai has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Ewelina Biskup, Xiao Yan Zhong, Minghong Wang, Bei Zhang, Lu Cai, Weijie Chen, Zeinab Barekati, Xiaoyan Lin, Hongyi Zhang and Haifeng Ye. Their work appears in journals such as Tumor Biology, Frontiers in Oncology, PLoS ONE, Oncotarget and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.